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ABSTRACT: 
Background: Necrotizing enterocolitis (NEC) continues to be a devastating condition 
among preterm infants.  Nitric oxide, which is synthesized in the intestine by endothelial 
nitric oxide synthase (eNOS), acts as a potent vasodilator and antioxidant within the 
mesentery and may play a role in prevention of NEC. We hypothesized that loss of 
endothelial nitric oxide would worsen both intestinal and associated lung injury and 
increase local and systemic inflammation during experimental NEC. 
 
Methods:  NEC was induced in five-day-old wild type (WT) and eNOS-knockout 
(eNOSKO) mouse pups.  Experimental groups (n=10) were formula fed and subjected 
to intermittent hypoxic and hypothermic stress, while control groups (n=10) remained 
with their mother to breastfeed.  Pups were monitored by daily clinical assessment.  
After sacrifice on day nine, intestine and lung were assessed for injury, and cytokines 
were measured in tissue homogenates by ELISA.  Data was compared with Mann-
Whitney, and p<0.05 was significant. 
 
Results: Each NEC group was compared to its respective strain’s breastfed control to 
facilitate comparisons between the groups.  Both NEC groups were significantly sicker 
than their breastfed controls. eNOSKO NEC animals had a median clinical assessment 
score of 3 (IQR=1-5), and the WT NEC animal’s median score was 3 (IQR=2-5). 
Despite similar clinical scores, intestinal injury was significantly worse in the eNOSKO 
NEC groups compared to WT NEC groups (median injury scores of 3.25 (IQR=2.25-
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3.625) and 2 (IQR=1-3), respectively (p=0.0474).  Associated lung injury was 
significantly worse in the eNOSKO NEC group as compared to the WT NEC group 
(median scores of 8.5 (IQR=6.75-11.25) and 6.5 (IQR=5-7.5), respectively, p=0.0391).  
Interestingly, cytokines in both tissues were very different between the two groups, with 
varying effects noted for each cytokine (IL-6, IL-1, VEGF, and IL-12) in both tissues.  
 
Conclusion: Nitric oxide from eNOS plays a key role in preventing the development of 
NEC.  Without eNOS function, both intestinal and lung injury are more severe, and the 
inflammatory cascade is significantly altered.  Further studies are needed to determine 
how eNOS-derived nitric oxide facilitates these beneficial effects. 
 
 
KEYWORDS 
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INTRODUCTION: 
 Necrotizing enterocolitis (NEC) is one of the most common and morbid 
conditions in the premature neonatal population [1].  It affects about 7% of preterm 
infants, and unfortunately has proven difficult to eradicate over the years.  Mortality 
continues to range from 20 to 30%, and is highest in patients with surgical disease [2].  
Extensive surgical resection remains the mainstay of therapy for advanced disease, and 
often leads to long term morbidity secondary to short bowel syndrome [3].  New 
therapies for this disease are needed, and further understanding of the mechanism of 
disease is integral for further research in this direction. 
  Unfortunately, the sequelae of NEC are not limited to the intestine.  Associated 
lung injury is a well-described phenomenon in NEC patients and animal models [4].  
One of the highest risk factors for development of chronic lung disease in premature 
infants is the presence of necrotizing enterocolitis [5].  Additionally, lung disease in 
patients with NEC is commonly more severe than in matched patients without NEC [6].   
 The development of NEC is multifactorial, but seems to be directly related to 
intermittent insults secondary to hypoxia, hypothermia and enteral feeding in an already 
susceptible intestine [7].  The pathogenesis is complex and not completely understood.  
While intestinal mucosal epithelial injury is a defining characteristic of NEC, 
microvascular injury, and specifically, endothelial alterations, are thought to play a role 
as well [8].   
Endothelial nitric oxide synthase (eNOS) is a constitutively-expressed enzyme 
that produces nitric oxide [9].   NO is a gaseous signaling molecule endogenously 
produced in the endothelium of all tissues by eNOS and has been identified as the most 
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important vasodilator in the perinatal period in animal models [10].  Mice with 
homozygous knockout of eNOS (eNOSKO) were found to have worse experimental 
NEC pathology in the intestine [9, 11].  Another study demonstrated that L-arginine, an 
eNOS substrate, reduced injury, while nitric oxide inhibitors such as N-nitroarginine 
methyl ester (L-NAME) worsened injury in a neonatal piglet model of NEC [12].  The 
role of eNOS has not yet been thoroughly evaluated in the lungs of animals with 
experimental NEC. 
In addition to direct impact on the affected tissues, as a free radical, NO is 
intimately involved in the inflammatory signaling seen in necrotizing enterocolitis [13].   
Specifically, certain cytokines are known to have a close relationship with endothelial 
NO as a mediator in the inflammatory cascade. For example, interleukin 6 (IL-6) has 
been shown to be modulated by NO in some tissues [14].  Vascular endothelial growth 
factor (VEGF) is an endothelial specific marker that is typically elevated during 
endothelial cell injury or hypoxia, but is dependent on nitric oxide for release [15].  
Interleukin 1 (IL-1) is also typically released by the endothelium in response to stress 
[16].  Finally interleukin 12 (IL-12) has been shown in vitro to be upregulated in the 
endothelium by inhibition of eNOS [17].  These are just a few of the cytokines involved 
in the complex systemic response to inflammation, of which endothelial NO is an 
integral mediator. 
Observations in animal studies suggest that eNOS has a critical role in the 
development of NEC intestinal injury.  We therefore hypothesized that eNOS would not 
only be a key component in limiting intestinal injury, but would also play a key role in 
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limiting lung injury and altering the systemic inflammatory response during experimental 
NEC.  
MATERIALS AND METHODS 
Experimental NEC Model: 
Indiana University Institutional Animal Care and Use Committee approved the 
experimental protocol and animal use.  Wild type (WT) mouse pups (C57BL/6J, bred in 
house from adult mice, Stock No: 00664, Jackson Laboratory, Bar Harbor, ME) and 
eNOSKO mice (B6.129P2-Nos3tm1Unc/J, bred in house from adult mice, Stock No: 
002684, Jackson Laboratory, Bar Harbor, ME) were permanently separated from their 
mother on postnatal day (P) five.  Pups were housed in a neonatal incubator with 
humidity 40% and temperature 32°C from P5 to P9.  All groups had 10 pups per group.  
The control groups of both strains remained with their mother and breastfeed ad libitum.  
Experimental groups were gavage fed hyperosmolar formula three times daily with a 2-
French silicone catheter.  Formula was prepared using 4g of Esbilac canine supplement 
and 6g Similac in 20 mL of nanopure filtered water (Barnstead Nanopure, APS Water 
Services Inc., Van Nuys, CA).  Formula was newly prepared every 48 hours.  Animals 
were fed 300 kcal/kg/day and all feeds were supplemented with 8 mg/kg/day 
lipopolysaccharide (LPS, lipopolysaccharides from Escherichia coli O111:B4, Sigma-
Aldrich Company LLC, Dorset, UK).   
 Before each feed, pups were stressed in a chamber with 5% O2 and 95% N2 for 
10 minutes.  Twice daily, after the morning and evening feeds, pups were placed in the 
4°C refrigerator for 10 minutes.   Because of the high rate of very low birth weight in the 
knock out strain specifically, litters with pups less than 1.5 grams in weight were 
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excluded due to the technical difficulties of gavage feeding animals this small.  Mice 
who died less than 24 hours into the protocol were excluded, as their death was more 
likely due to other causes than NEC.  Any animal whose tissue was liquefied or 
unusable for histologic evaluation (i.e. died overnight and discovered hours later) was 
excluded completely from evaluation.  Other animals that died during the study but were 
identified immediately were still included in analysis for all data points.  This included 1 
in the eNOSKO NEC group and 2 in the WT NEC group. 
 
Clinical Assessment: 
 While control groups were weighed and assessed daily to minimize maternal 
separation, experimental groups were weighed daily but re-assessed with each feed.  
Assessment proceeded in a systematic fashion to ensure consistency.  The reported 
score is the pup’s last score prior to death or euthanasia.  Clinical sickness score was 
slightly modified from Zani et. al. [18] to include specific criteria for scoring as previously 
reported. 
 
Intestinal Histologic Evaluation: 
 On P9, pups were sacrificed by decapitation and the terminal ileum and distal 
jejunum of each animal was then formalin fixed, paraffin embedded, and stained with 
hematoxylin and eosin.  Two blinded authors evaluated degree of injury, and scores 
were averaged for each specimen.  The scoring system used was published by Zani et. 
al. [18] with scores ranging from 0 to 4.  0 = normal intestine; 1 = disarrangement of 
villus enterocytes, villus-core separation; 2 = significant disarrangement of villus 
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enterocytes, villus-core separation down sides of villi, blunting of villi; 3 = epithelial 
sloughing of villi, loss of villi; 4 = intestinal necrosis or perforation.  A score of 2 or higher 
was considered consistent with development of experimental NEC.  Severe NEC was 
defined as grade 3 or 4 intestinal injury. 
 
Lung Histologic Evaluation: 
 At the time of euthanasia, the right lower lobe of the lung was formalin fixed, 
paraffin embedded, and stained with hematoxylin and eosin.  Two blinded authors 
evaluated degree of injury using a modified version of the scale developed by the 
American Thoracic Society (ATS).  The scale was modified to be more appropriate for 
immature lungs (Table 1).  Scores from 0 (normal) to 2 (acute lung injury) are given in 
six different parameters and added together to yield a score between 0 and 12, with 0 
representing normal lung and 12 indicating severe acute injury with hemorrhage [19].   
 
Cytokine Analysis: 
Following euthanasia, sections of small intestine and lung were snap frozen in 
liquid nitrogen and stored at -80°C.  Tissue was thawed and homogenized with the 
Bullet Blender (Next Advance, Averill Park, NY) in RIPA buffer (Sigma, St. Louis, MO) 
with 1:100 dilutions of both phosphatase and protease inhibitors (Sigma, St. Louis, MO).  
After homogenization, samples were centrifuged at 12,000 rpm and supernatants were 
collected for further analysis.  Total protein was quantified with the Bradford Assay 
using a spectrophotometer (VersaMax microplate reader, Molecular Devices, 
Sunnyvale, CA). 
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 Murine interleukin 6 (IL-6), vascular endothelial growth factor (VEGF), interleukin 
1β (IL-1β), and interleukin 12 (IL-12) were measured by ELISA (R&D Systems, Bio-
Techne Corporation, Minneapolis, MN).  ELISAs were repeated twice to ensure 
consistency.  In order to correct for variations in ELISA plates, values for both WT and 
eNOSKO mice were normalized to their respective breastfed controls and therefore 
concentrations are expressed as “fold change compared to control.”  Assays were 
performed at 1:20 dilution and cytokine concentrations were normalized to total protein 
for each sample. 
 
Statistical Analysis: 
 Continuous variables were reported as mean ± standard error of mean (SEM) 
and ordinal variables were reported using median and interquartile range.  All non-
parametric data was compared with Mann-Whitney U-tests.  GraphPad Prism 7 
(GraphPad Software, La Jolla, CA) was used for all statistical analysis and figures.  P 
values less than 0.05 were considered significant. 
RESULTS 
Loss of eNOS does not worsen overall clinical sickness in NEC. 
 The breastfed eNOSKO pups had reduced weight gain (1.69g ± 0.11) over the 
four-day protocol compared to WT (2.23g ± 0.10, p=0.0015).  This may indicate a 
reduction in baseline health compared to the WT pups.  In both WT NEC and eNOSKO 
NEC groups, there was little to no weight gain over the course of the four-day 
experiment with no significant difference between the NEC groups (Figure 1A).   
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 Clinical assessment scores for both NEC groups were significantly higher 
(worse) compared to their respective controls (p<0.0001 for each), but there was no 
difference between clinical scores in the WT and eNOSKO NEC groups (Figure 1B).   
 
Loss of eNOS increases severity of intestinal injury 
 At baseline, the WT and eNOSKO breastfed groups had similar intestinal 
appearances, with median histologic scores of 0 (IQR=0-0) and 0 (IQR=0-1) 
respectively.  Both NEC groups had significantly worse intestinal injury compared to 
their respective controls.  The eNOSKO NEC group had a median histologic injury score 
of 3.25 (IQR=2.25-3.625) and the WT NEC group had a median score of 2 (IQR=1-3, 
p=0.0474, Figure 2A).  The eNOSKO NEC group had a higher incidence of NEC 
development as well as a higher incidence of severe NEC, defined as grade 3 and 4 
injury (Figure 2B).   
 
Loss of eNOS increases severity of NEC-associated lung injury 
 At baseline, the breastfed eNOSKO group had more significant lung injury, with a 
median score of 4 (IQR=3.75-4.25) compared to 2.5 (IQR=0.75-4) in the breastfed WT 
group (p=0.0099).  After exposure to the NEC model, the eNOSKO NEC group 
developed more significant lung injury with a median score of 8.5 (IQR=6.75-11.25) 
compared to 6.5 (IQR=5-7.5) in the WT NEC group (Figure 3).   
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Loss of eNOS leads to altered intestinal inflammatory response 
 IL-6 was increased in the eNOSKO NEC group (1.414 ± 0.1872) compared to the 
WT NEC group (0.6187 ± 0.04663, p=0.0003).  VEGF was significantly higher in the WT 
NEC group (2.473 ± 0.3057 compared to the eNOSKO NEC group (1.051 ± 0.2509, 
p=0.0008).  IL-1β was higher in eNOS NEC (1.446 ± 0.2007 compared to WT NEC 
(0.6104 ± 0.0507, p=0.0005).  Finally, intestinal IL-12 was significantly higher in eNOS 
NEC (1.458 ± 0.1593) compared to WT NEC (0.622 ± 0.0506, p=0.0002, Figure 3). 
 
Loss of eNOS leads to altered lung inflammatory response 
 Lung IL-6 was significantly lower in the WT NEC group (0.5899 ± 0.05402) 
compared to the eNOSKO NEC group (0.8189 ± 0.0860, p=0.0320).  Average lung 
VEGF levels were lower in WT NEC (0.8055 ± 0.0380) compared to eNOSKO NEC 
(0.9944 ± 0.1058), but there was no significant difference between the two groups.  
Lung IL-1β was significantly higher in WT NEC (1.194 ± 0.0722) compared to eNOSKO 
NEC (0.6934 ± 0.0809, p=0.0002, Figure 4).  Lung IL-12 was not significantly different 
between the WT and eNOSKO NEC groups (0.724 ± 0.0737 vs. 0.773 ± 0.0733. 
 
DISCUSSION 
Endothelial nitric oxide synthase (eNOS) is thought to play an integral role in 
intestinal microcirculatory regulation, especially in the neonatal period [10].  In the 
intestine, eNOS expression is upregulated by enteral feeding, which helps to modulate 
the microcirculatory response in mature tissues [20]. Therefore, it stands to reason that 
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knocking out the function of this enzyme, reducing the ability of the intestine and 
mesentery to produce nitric oxide, would worsen intestinal injury in necrotizing 
enterocolitis [21].  This has been demonstrated in previous studies, but the effect of 
eNOS ablation on the NEC-associated lung injury has not been as well studied.  In our 
study, we demonstrated significantly worse intestinal and lung injury in eNOSKO mice 
exposed to an animal model of NEC as well as dysregulation of the intestinal and 
pulmonary inflammatory response in experimental NEC. 
 Surprisingly, clinical scores were not significantly worse with loss of eNOS.  
While intestinal injury was certainly worse, the eNOSKO pups seemed to be able to 
compensate enough via other pathways to reduce overall clinical deterioration.  A 
previous study has shown that LPS-induced systemic septic shock is less severe in 
eNOSKO mice as compared to wild type animals, likely because eNOS acts as both a 
direct producer and an indirect regulator of NO production [22]. Downregulation of NO 
reduces the systemic hypotension and vascular permeability that characterizes shock 
[15, 23].  Therefore, despite the increased injury in the intestine and lung in eNOSKO 
mice, they may be somewhat protected from the overall septic picture and worsening 
clinical status when compared to wild type mice. 
We did note more severe intestinal injury in eNOSKO pups.  A previous study 
has demonstrated that endothelial toll-like receptor 4 (TLR4) signaling acts through 
downregulation of eNOS to modulate intestinal perfusion and exacerbate NEC [9].  In 
that study, when TLR4 was knocked out, relative eNOS activity was increased, leading 
to less severe NEC [9]. Lack of eNOS activity exerts the opposite effect, and alters the 
delicate microcirculation of the neonatal intestine, which is predominantly regulated by 
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nitric oxide at this stage, resulting in more severe injury [21].  In this era of research, 
reproducibility of results is not always appreciated, but our work serves to support this 
proposed mechanism.   
Lung injury was also more severe in the eNOSKO NEC pups compared to WT.  
While part of this may be partially due to the baseline differences in the lungs between 
the knock-out and wild-type mice, the injury secondary to the NEC model was certainly 
more severe in the eNOSKO NEC group.  In previous studies, this injury has been 
shown to be secondary to intestinal NEC and its resulting systemic effects, not direct 
injury to the lung, as expected based on human data [4].  Additionally, as we have 
confirmed in this study, eNOSKO mice suffer more severe intestinal injury secondary to 
NEC [9, 21], which likely explains the more severe lung injury in these animals as well.   
  Loss of eNOS activity was found to significantly alter the inflammatory response 
in both intestine and lung.  In non-stressed endothelium, NO is constitutively produced 
by eNOS at steady states, which maintains hemostasis and keeps vascular structure 
intact [24].  Stimulation by any sort of stress induces NO production, which contributes 
to the vascular permeability associated with inflammation [24].  Because of this, loss of 
endothelial nitric oxide significantly impacts the inflammatory response.  We chose to 
look at IL-6, IL-1β, IL-12, and VEGF based on findings in previous studies which have 
demonstrated alterations in these cytokines in experimental NEC [13, 25-28], as well as 
studies showing intimate involvement of endothelial NO with production of these 
cytokines [14-17], and these were the only cytokines evaluated. 
IL-6 was elevated in eNOSKO NEC group’s intestine compared to WT NEC 
group.  IL-6, while typically thought of as a pro-inflammatory cytokine, has been shown 
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to play a more protective role in the intestine and may act as an anti-inflammatory 
mediator in NEC [29].  Additionally, previous studies have shown multiple interactions 
between IL-6 and NO.  In macrophages stimulated by LPS, a NO inhibitor has been 
shown to increase IL-6 release [30], indicating that a loss of eNOS may result in 
increased IL-6 during inflammation.  In the lung, IL-6 was higher in the eNOSKO NEC 
group than the WT NEC group.  Because IL-6 release is at least partially modulated by 
nitric oxide, it is reasonable that the eNOSKO NEC pups would have higher IL-6 in the 
lung compared to WT NEC after prolonged and repeated systemic insult. 
 A significant difference between WT and eNOSKO pups was noted in VEGF 
production.  The WT group had significantly elevated intestinal VEGF and decreased 
VEGF in the lung, while the eNOSKO NEC group exhibited no change from baseline in 
either tissue.  VEGF is a growth factor that is typically released by endothelial cells in 
response to hypoxic stress [16].  Therefore, VEGF was expected to increase during 
NEC in intestinal tissue, however it’s response in the lung is not well understood.  VEGF 
also plays an important role in inflammation as a inducer of vascular permeability and 
stimulator of angiogenesis [24].  Previous studies have shown that VEGF is 
predominantly dependent on eNOS-derived NO to provide these effects [15].  
 Significant differences were noted in the production of IL-1β in both intestine and 
lung.  In the intestine, IL-1β was decreased in the WT NEC group compared to the 
eNOSKO NEC group, while the opposite effect was noted in the lung.  One function of 
IL-1 is to activate endothelial cells and stimulate NO production [31].  Theoretically, 
loss of endothelial NO would decrease negative feedback of IL-1 and increase its 
production in response to injury.  Systemically, IL-1β acts a neutrophil chemoattractant, 
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and therefore it is expected that it would be increased in the WT NEC lungs.  The result 
in the eNOSKO pups is more surprising.  A study in organoids of human pulmonary 
artery endothelial cells demonstrated that expression of eNOS was intimately linked to 
hypoxia and LPS-induced stress as well as IL-1β concentration over time [32].  In 
stressed conditions, IL-1β contributes to downregulation of eNOS expression [32].  In 
the case of eNOSKO pups, the lungs may decrease IL-1β production due to absence of 
eNOS.    
 IL-12 was depressed in WT NEC intestine, compared to eNOSKO NEC.  
Previous studies have demonstrated decreased IL-12 in intestinal epithelium in 
experimental NEC [26], so this was anticipated in our WT group.  Previous studies in 
human endothelial cells have demonstrated upregulation of IL-12 expression by 
inhibition of eNOS activity, and downregulation in the presence of endogenously 
produced NO [17], which is supported by our observations in this study.  In the lung, 
there was no difference in IL-12 between WT NEC and eNOSKO NEC, which is not fully 
understood.  In previous experimental NEC studies, IL-12 has mainly been evaluated in 
the intestine [26], and further work to elucidate its role in the lung would be useful. 
 In addition to more severe intestinal and lung injury secondary to the NEC model, 
the inflammatory responses of the intestine and lung vary widely between the two 
strains.  It is clear that nitric oxide plays an integral role in inflammation, sepsis, and 
systemic injury, and additional research is certainly needed to further elucidate these 
interactions. 
  
LIMITATIONS 
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Because the pathophysiology of NEC is not completely understood, experimental 
models of NEC are limited.  The diagnosis can only be truly established at postmortem 
examination of the intestine, which makes it difficult to assess development of NEC 
during progression of the protocol.  Additionally, blinding the clinical assessments of the 
animals is difficult, but this was standardized as much as possible by a regimented 
scoring system and inclusion of other more objective measures.  Specific challenges 
with the eNOSKO mice include difficult and unpredictable breeding and high 
cannibalism rate of pups.  Additionally, a high rate of low birth weight was noted, with 
some pups weighing under 1 gram on P5.  Litters with pups under 1.5 grams on P5 
were excluded after multiple deaths related to technical difficulties of gavage feeding 
pups this small. 
 
CONCLUSION 
Endothelial nitric oxide synthase plays an integral role in protection of the 
intestine and lung in experimental NEC.  The inflammatory response both locally in the 
intestine and systemically is significantly altered in the absence of eNOS in knock-out 
mice.    
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FIGURE LEGENDS 
 
Figure 1: Loss of eNOS did not result in significant change in clinical severity of NEC.  
A) There was a significant difference between weight gain over the four-day protocol in 
the breastfed groups (#: p=0.0015 vs WT Breastfed) indicating a possible baseline 
health deficiency in the eNOSKO pups.  Each NEC group had little to no weight gain 
over the length of the protocol (*: p<0.0001 vs. respective breastfed control).  B) Clinical 
assessment scores of each group were significantly worse than their respective controls 
(*: p<0.0001), but there was not a significant difference between WT and eNOSKO NEC 
groups.   
 
Figure 2: Loss of eNOS results in more severe intestinal injury secondary to NEC.  A) 
Histologic injury scores were significantly worse in both NEC groups compared to the 
breastfed pups, and the eNOSKO NEC group had more severe injury than the WT NEC 
group. (*: p<0.05 vs. respective breastfed control, #: p<0.05 vs. WT NEC).  B) The 
eNOSKO NEC group developed NEC at a higher rate and developed more severe NEC 
compared to WT.  C) Representative histologic sections of each group (H&E stained, 
20x magnification) demonstrate villus disarrangement and villous sloughing in the NEC 
groups, with significant villous core separation noted specifically in the eNOSKO NEC 
group. 
 
Figure 3: Loss of eNOS results in more severe lung injury secondary to NEC.  A) Lung 
injury scores in eNOSKO mice was significantly worse than their WT counterparts in 
both the breastfed and NEC groups (*: p<0.05 vs. respective breastfed control, #: 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
 
 
p<0.05 vs. WT NEC, $: p<0.05 vs. WT breastfed).  B) Representative histologic 
sections of each group (H&E stained, 40x magnification) demonstrate relative alveolar 
septal thickening, fibrinous and cellular airspace deposits, increased neutrophils, and 
blood in the airspaces in the NEC groups. 
 
Figure 4: Loss of eNOS results in altered intestinal inflammatory response.  
Concentrations of cytokines are expressed as folds of control (breastfed group).  IL-6, 
VEGF, IL-1β, and IL-12 had varying responses in eNOS and WT NEC, with significant 
differences between the two NEC groups for all four cytokines.  (*: p<0.05 vs. WT NEC) 
 
Figure 5: Loss of eNOS results in altered pulmonary inflammatory response.  
Concentrations of cytokines are expressed as folds of control (breastfed group).  There 
is a significant difference in IL-6 and IL-1β between the two NEC groups, but no 
difference in VEGF or IL-12. (*: p<0.05 vs. WT NEC) 
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Table 1. Lung Injury Scoring System 
Parameter 
Score per field (400x magnification) 
0 1 2 
Neutrophils in the alveolar space None 1-5 >5 
Neutrophils in the interstitial space None 1-5 >5 
Hyaline membranes None 1 >1 
Proteinaceous debris filling the airspaces None 1 >1 
Alveolar septal thickening <2x 2x-4x >4x 
Red blood cells in alveolar space Few Half filled Filled  
Lung injury score = sum of all scores, range from 0 to 12 
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